| Net Cash Provided by (Used in) Operating Activities |
-1,117,000 |
USD |
-21.5% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-16,000 |
USD |
+99% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-1,000 |
USD |
+96.2% |
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
114,900,000 |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.52 |
USD/shares |
|
Q2 2023 |
Q3 2023 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
18,622,000 |
USD |
-5% |
Q2 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
28,000 |
USD |
-12.5% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
13,220,000 |
USD |
|
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
13,441,000 |
USD |
+10.5% |
Q3 2024 |
FY 2024 |
| Depreciation |
244,000 |
USD |
-18.9% |
Q2 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
1,000 |
USD |
-96.2% |
Q4 2024 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
2,020,000 |
USD |
-53.6% |
Q2 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
1,050,000 |
USD |
-14.4% |
Q2 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
0 |
USD |
-100% |
Q4 2023 |
Q1 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
5,950,000 |
USD |
+36.2% |
Q3 2024 |
FY 2024 |
| Amortization of Intangible Assets |
859,000 |
USD |
-70.2% |
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
9,495,000 |
USD |
+34.4% |
Q3 2024 |
FY 2024 |
| Interest Expense |
340,000 |
USD |
+6.2% |
Q2 2025 |
Q3 2025 |